Univercells acquires SynHelix, enters synthetic biology field
Belgium’s Univercells has acquired SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through automated DNA synthesis.
Archives for January 6, 2022
Clover Biopharmaceuticals begins construction of new R&D center in Shanghai
Clover Biopharmaceuticals, a clinical-stage biotech developing novel vaccines and biologic therapeutic candidates, has started construction on a new R&D Center in Zhangjiang Biotech and Pharmaceutical Industrial Base in Shanghai.
Shingles is new focus for Pfizer and BioNTech in mRNA vaccine development partnership
Pfizer and BioNTech, in what will be the third mRNA vaccine collaboration between the two companies, are teaming up on the development of a vaccine for the prevention of shingles.
Texcell North America starts work on new Maryland facility
Contract Research Organization (CRO) Texcell has held a breaking ground ceremony for a new facility in Frederick, MD.